| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/10/2005 | US20050054056 Mesothelin specific immunoglobulin for use as diagnostic tool in detection of cell proliferative disorders; immunotherapeutics |
| 03/10/2005 | US20050054055 Using transgenic rodents as bioreactor for generation of immunoglobulins for use as tools in immunotherapeutics and diagnostics |
| 03/10/2005 | US20050054048 Generating preferential immunoglobulins in hypermutable cells for use as tools in antibody-dependent cellular cytotoxicity; immunotherapy |
| 03/10/2005 | US20050054046 Evaluating safety, efficacy and biological properties of immunoglobulin receptors; immunotherapeutic agents |
| 03/10/2005 | US20050054045 Novel G-protein coupled receptor |
| 03/10/2005 | US20050054036 Growth factor isoform |
| 03/10/2005 | US20050054034 Polypeptide encoding by a polynucleotide; for detecting diseases; use in diagnosis and in identifying compounds that may be agonists, antagonists as biodrug treating diseases; host cell culturing |
| 03/10/2005 | US20050054020 Protein O-sulfonation |
| 03/10/2005 | US20050054019 Human monoclonal antibody for use in the diagnosis prevention and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics |
| 03/10/2005 | US20050054017 Using phosphorylated p21-activated protein kinases (PAK) as diagnostic tool in identifying modulator for prevention and treatment of cell proliferative disorders |
| 03/10/2005 | US20050054016 Determination of bone-sialoprotein in bodily fluids for oncological problems |
| 03/10/2005 | US20050054007 Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof |
| 03/10/2005 | US20050054001 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
| 03/10/2005 | US20050054000 Immunoglobulin construct comprising leukocyte receptor and variable regions for use as tool in enrichment for preferential bioparticles |
| 03/10/2005 | US20050053995 Staphylococcus aureus genes and polypeptides |
| 03/10/2005 | US20050053993 Uses of an endothelial cell receptor |
| 03/10/2005 | US20050053945 Nucleosides; bioconjugation; solid phase synthesis |
| 03/10/2005 | US20050053935 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer |
| 03/10/2005 | US20050053925 Epitopes; immunoglobulins; hybridomas; diagnostic kits |
| 03/10/2005 | US20050053924 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease |
| 03/10/2005 | US20050053919 Using negative-sense single stranded RNA viral sequences as diagnostic tool in detection of respiratory syncytial viral infection |
| 03/10/2005 | US20050053918 Method of identifying peptides capable of binding to MHC molecules, peptides identified thereby and their uses |
| 03/10/2005 | US20050053914 Nucleotide sequences coding hepatitis envelope protein for use as tool in detecting hepactocyte receptors; drug screening, viricides and treatment of viral diseases |
| 03/10/2005 | US20050053707 Cross-flow filtration, chromatography, fermentation; reducing wastes |
| 03/10/2005 | US20050053616 peptides based on conserved regions of regulatory and auxiliary HIV proteins, antigens in free or carrier-bound form comprising one of the peptides, vaccine compositions containing one of the antigens, immunoassay kits and a method of detecting antibodies, induced by HIV using such antigens |
| 03/10/2005 | US20050053614 Prevention and treatment of amyloidogenic disease |
| 03/10/2005 | US20050053611 Antibody directed enzyme prodrug therapy and a kit with antihumanseminal plasma protein single chain antibodies and prodrugs |
| 03/10/2005 | US20050053610 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease |
| 03/10/2005 | US20050053609 Cancerous disease modifying antibodies |
| 03/10/2005 | US20050053608 Using monoclonal antibody/maytansine fusion as tool in treatment and prevention of cell proliferative disorders; immunotherapy; tissue targeted therapy |
| 03/10/2005 | US20050053606 MUC1 extracellular domain and cancer treatment compositions and methods derived therefrom |
| 03/10/2005 | US20050053605 Methods and compositions for treating herpes infections |
| 03/10/2005 | US20050053604 Administering avian polyclonal antibodies to treat inflammatory bowel disease in birds or humans and for colitis including Crohn's disease |
| 03/10/2005 | US20050053602 Therapy of ocular disorders |
| 03/10/2005 | US20050053600 Using humanized antibodies to treat rheumatoid arthritis |
| 03/10/2005 | US20050053599 Antagonist for endothelial growth agents for treatment of edema and for kidney dialysis |
| 03/10/2005 | US20050053598 Immunoglobulin formulation and method of preparation thereof |
| 03/10/2005 | CA2548483A1 Induction of antiviral neutralizing antibodies in humans and animals |
| 03/10/2005 | CA2543078A1 Diagnosis and treatment of micobacterial infections |
| 03/10/2005 | CA2542372A1 Method of promoting graft survival with anti-tissue factor antibodies |
| 03/10/2005 | CA2537928A1 Method of treatment and bioassay involving macrophage migration inhibitory factor (mif) as cardiac-derived myocardial depressant factor |
| 03/10/2005 | CA2537140A1 Gastric and prostate cancer associated antigens |
| 03/10/2005 | CA2536911A1 Antibody against nox1 polypeptide, method of diagnosing cancer with the use of nox1 gene and method of screening cancer growth inhibitor |
| 03/10/2005 | CA2536675A1 A rapid way to obtain high expression clones of mammalian cells using a methylcellulose and immunoprecipitation screening method |
| 03/10/2005 | CA2536205A1 Human obesity susceptibility gene and uses thereof |
| 03/10/2005 | CA2536067A1 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for these populations |
| 03/10/2005 | CA2535526A1 Laccases, nucleic acids encoding them and methods for making and using them |
| 03/10/2005 | CA2533379A1 Monoclonal antibodies against ricin toxin and methods of making and using thereof |
| 03/10/2005 | CA2532737A1 Method for the production of porous carbon-based molded bodies, and use thereof as cell culture carrier systems and culture systems |
| 03/10/2005 | CA2529710A1 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using |
| 03/09/2005 | EP1512746A1 Method for the production of a polypeptide, RNA or other compound in tumor tissue |
| 03/09/2005 | EP1512740A1 Synthase of cereulide produced by bacillus cereus, gene encoding the same and method of detecting cereulide |
| 03/09/2005 | EP1512697A1 TNF Receptor action modulation |
| 03/09/2005 | EP1512696A1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 03/09/2005 | EP1512414A1 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 03/09/2005 | EP1512412A1 Method to identify anti-apoptotic compounds |
| 03/09/2005 | EP1512017A2 Extraction and quantification of vitamins a & d in fluid samples |
| 03/09/2005 | EP1512014A2 Methods for the identification of all-antigens and their use for cancer therapy and transplantation |
| 03/09/2005 | EP1512004A2 Method for mapping and eliminating t-cell epitopes |
| 03/09/2005 | EP1511864A2 Viral capsid assembly intermediates |
| 03/09/2005 | EP1511861A2 Methods and compositions for milieu-dependent binding of a targeted agent to a target |
| 03/09/2005 | EP1511859A1 Diagnosis of abnormal blood conditions based on polymorphisms in the glycoprotein vi gene |
| 03/09/2005 | EP1511772A2 Method for obtaining anti-idiotype antibodies |
| 03/09/2005 | EP1511771A1 Anti-aurora-a monoclonal antibody, method for obtaining same, and uses thereof for diagnosing and treating cancers |
| 03/09/2005 | EP1511770A2 Immunoadhesin comprising a glycoprotein vi domain |
| 03/09/2005 | EP1511762A2 Detection of secreted polypeptides |
| 03/09/2005 | EP1511759A1 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof. |
| 03/09/2005 | EP1511480A2 Inhibitors of glycoprotein vi |
| 03/09/2005 | EP1511391A2 Capture, concentration and quantitation of abnormal prion protein from biological fluids using depth filtration |
| 03/09/2005 | EP1392354B1 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic wounds |
| 03/09/2005 | EP1237916B1 Ing2, an iaps associated cell cycle protein, compositions and methods of use |
| 03/09/2005 | EP1108026B1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same |
| 03/09/2005 | EP1021460A4 Laminins and uses thereof |
| 03/09/2005 | EP0876612B1 Method for identifying sex specific and species specific molecules, molecules identified using the method, and uses of the molecules |
| 03/09/2005 | EP0842273B1 Receptor ligand vegf-c |
| 03/09/2005 | EP0801679B1 Monoclonal antibodies which promote central nervous system remyelination |
| 03/09/2005 | EP0756005B1 Gene coding for adseverin |
| 03/09/2005 | CN1592793A Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 03/09/2005 | CN1592791A Phytases, nucleic acids encoding them and methods for making and using them |
| 03/09/2005 | CN1592754A Food allergens, method of detecting food allergens and method of detecting food allergy-inducing foods |
| 03/09/2005 | CN1592645A Combination therapy for treatment of autoimmune diseases using B cell depleting/immunoregulatory anti-body combination |
| 03/09/2005 | CN1592636A Immunotherapeutic combinations for the treatment of tumors |
| 03/09/2005 | CN1590409A Antibody pointed at SARS coronavirus N protein antigen and its use in detecting SARS coronavirus or its antigen |
| 03/09/2005 | CN1590405A White candidas transcription factor gene and its use |
| 03/09/2005 | CN1590404A Antigenic meningococcal peptides |
| 03/09/2005 | CN1589903A Methods for amyloid removal using anti-amyloid antibodies |
| 03/09/2005 | CN1589902A Application of anti-lymphotoxin-beta receptor antibodies in preparation of medical composition |
| 03/09/2005 | CN1192236C In vitro method for determining presence of protein in separated biological sample |
| 03/09/2005 | CN1192038C Monoclonal antibodies against HIV-1 and vaccines made thereof |
| 03/09/2005 | CN1191861C Medicinal compositions containing anti-Fas antibody |
| 03/09/2005 | CN1191860C Method for treatment of fibrosis using antagonist of integrin alpha-4 subunit |
| 03/09/2005 | CN1191858C Method for inhibiting brain tnmor growth |
| 03/09/2005 | CN1191856C Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke |
| 03/09/2005 | CN1191855C Remedies for lymphocytic tumors |
| 03/09/2005 | CN1191851C Polypeptide comprising amino acid of AN N-terminal choline binding protein truncate, vaccine derived therefrom and uses thereof |
| 03/09/2005 | CN1191850C Treatment of hemoatological malignancies associated with circulating tumor cells using chimeric anti -CD20 antibody |
| 03/09/2005 | CN1191823C Cell for producing alginate capsules |
| 03/08/2005 | US6864358 Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor |
| 03/08/2005 | US6864227 Artery-and vein-specific proteins and uses therefor |
| 03/08/2005 | US6864076 Protein for use in the prevention of fungal infection |